# Ciprofol vs Propofol for Reducing Hypoxia Incidence in ERCP

> **NCT06015074** · NA · NOT_YET_RECRUITING · sponsor: **RenJi Hospital** · enrollment: 136 (estimated)

## Conditions studied

- Anesthesia; Adverse Effect
- Biliary Tract Diseases

## Interventions

- **DRUG:** Propofol
- **DRUG:** Ciprofol

## Key facts

- **NCT ID:** NCT06015074
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06-15
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-02-28
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2024-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06015074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06015074, "Ciprofol vs Propofol for Reducing Hypoxia Incidence in ERCP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06015074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*